These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3319421)

  • 21. [Possible use of a single test culture in determining the biological activity of polyene antibiotics].
    Fradkova TA
    Antibiotiki; 1979 Jan; 24(1):55-60. PubMed ID: 570822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of antifungal agents in combination with four quinolones.
    Petrou MA; Rogers TR
    Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C; Goudard M; Blancard A; Quilici M; Regli P
    Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
    Garavelli PL; Michelone G; Cavanna C; Maccabruni A
    Minerva Med; 1988 Apr; 79(4):265-6. PubMed ID: 3163414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimycotic activity in vitro and in vivo of a new hydrosoluble polyene antibiotic.
    Strippoli V; Evangelista AM; Simonetti N
    Farmaco Sci; 1976 Dec; 31(12):891-900. PubMed ID: 1017483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of resistance to azole antifungals.
    Marichal P; Vanden Bossche H
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
    Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal antibiotic sensitivity testing: use of Autobac 1 for standardization purposes.
    Seguela JP; Lepargneur JP; Saveres C; Cazaux M; Riser A; Linas MD
    Mycopathologia; 1980 Aug; 72(1):13-9. PubMed ID: 7421978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
    Morita T; Nozawa Y
    J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an azole-resistant Candida glabrata isolate.
    vanden Bossche H; Marichal P; Odds FC; Le Jeune L; Coene MC
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2602-10. PubMed ID: 1482129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
    Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
    Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A
    Chemotherapy; 1978; 24(1):2-16. PubMed ID: 338264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.
    Young LY; Hull CM; Heitman J
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2717-24. PubMed ID: 12936965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antifungals cellular targets and mechanisms of resistance].
    Accoceberry I; Noël T
    Therapie; 2006; 61(3):195-9. PubMed ID: 16989119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do the polyene macrolide antibiotics affect the cellular membrane properties?
    Bolard J
    Biochim Biophys Acta; 1986 Dec; 864(3-4):257-304. PubMed ID: 3539192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic antifungal agents. Drug interactions of clinical significance.
    Albengres E; Le Louët H; Tillement JP
    Drug Saf; 1998 Feb; 18(2):83-97. PubMed ID: 9512916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical approaches to selective antifungal activity. Focus on azole antifungals.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC; Willemsens G; Bellens D; Roels I; Moereels H; Janssen PA
    Mycoses; 1989; 32 Suppl 1():35-52. PubMed ID: 2561184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Materials with fungi-bioinspired surface for efficient binding and fungi-sensitive release of antifungal agents.
    Segura T; Puga AM; Burillo G; Llovo J; Brackman G; Coenye T; Concheiro A; Alvarez-Lorenzo C
    Biomacromolecules; 2014 May; 15(5):1860-70. PubMed ID: 24712760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terbinafine: mode of action and properties of the squalene epoxidase inhibition.
    Ryder NS
    Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin.
    Joseph-Horne T; Manning N; Holoman D; Kelly S
    Phytochemistry; 1996 Jun; 42(3):637-9. PubMed ID: 8768319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.